Results
1 -
10 of
44Jeppesen P. B..
Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome, Therapeutic Advances in Gastroenterology, 2012 Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues, Cancer Chemotherapy and Pharmacology A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects, BMC Gastroenterology Use of Teduglutide to Reduce Parenteral Support in Short Bowel Syndrome, Diet and Nutrition in Critical Care Short Bowel Syndrome, Complexities in Colorectal Surgery Short Bowel Syndrome: Pharmacotherapy, Nutritional Management of Inflammatory Bowel Diseases Short Bowel Syndrome: Pharmacological Improvement of Bowel Function and Adaptation, Current Concepts of Intestinal Failure Medical Management of Short Bowel Syndrome and Nutritional Support, Mesenteric Vascular Disease Total Parenteral Nutrition and Inflammatory Bowel Disease: Indications, Long term Outcomes, and Complications, Nutritional Management of Inflammatory Bowel Diseases Short Bowel Syndrome: A Clinical Update, Surgery of Complex Abdominal Wall Defects